Instalab
logoInstalab

Babesia Microti Antibody IgM Screen

Blood Test
Investigate a tick-borne cause of fever and anemia that Lyme testing doesn't detect.
4.9 (4,913 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Babesia Microti Antibody IgM Screen test?

This test is most useful if any of these apply to you.

Feeling Sick After Tick Exposure
Fever, sweats or unusual fatigue after tick exposure can warrant a babesiosis workup; IgM provides supporting evidence.
Still Feverish During Lyme Treatment
Persistent fever, anemia or low platelets can point to another tick-borne infection and justify testing beyond Lyme.
Living Without a Spleen or With Low Immunity
Babesiosis can be more severe for you. Symptoms need prompt evaluation, even if an antibody screen is negative.
Following Up an Unexpected Positive
IgG, PCR and a blood smear can help clarify a positive screen before you make treatment or blood-donation decisions.

About Babesia Microti Antibody IgM Screen

Fever, sweats and persistent fatigue after time in tick habitat can come from babesiosis as well as other infections. A Lyme test looks for a different organism. Babesia microti IgM can support a babesiosis evaluation, but a positive screen alone can't establish that parasites are currently in your blood.

What the Result Measures

Babesia microti is a parasite that infects red blood cells. The illness it causes is called babesiosis. Destruction of red blood cells can cause anemia. Anemia reduces your blood's capacity to carry oxygen. Your immune system can make IgM antibodies early in infection, followed by IgG antibodies that often persist longer. The timing overlaps, and IgM can remain detectable for months after an infection has resolved.

This test detects IgM antibodies in serum by indirect immunofluorescence (IFA). Serum is the liquid left after blood clots. The assay uses a fluorescent label to reveal antibodies that bind to parasite material on slides.

The screen reports whether antibodies are detected. A positive screen may lead to a separately reported titer. A titer describes how far a sample can be diluted before its antibody reaction disappears. The screen itself has no numerical level to trend.

Antibody testing is an established supporting tool for babesiosis. Its main limitation is distinguishing active infection from past exposure or a false-positive reaction. A blood smear looks for parasites inside red blood cells, while PCR looks for their genetic material in whole blood.

The Window Before Antibodies Appear

The parasite can be present before your antibody response becomes detectable. The time from a tick bite to symptoms also varies, so counting days from the bite or from the first fever doesn't provide a dependable date when an IgM result becomes conclusive. A weakened immune system can delay or reduce antibody production further.

An early study of IgM IFA in New England detected about nine in ten acute cases. That finding supports the method's diagnostic usefulness, but it doesn't establish the accuracy of every commercial screen or its performance in people without symptoms.

Research assays are trying to detect antibody responses earlier. One study using a different method to measure IgG in human serum detected six of thirteen samples that were PCR-positive but negative by conventional antibody IFA. This was an IgG research assay, so the finding doesn't describe the performance of this IgM screen.

How Long a Positive Result Lasts

Antibodies can outlast the infection that triggered them. IgM positivity therefore suggests a possible recent response without reliably dating the infection. Studies of IgG and total antibodies have found positivity lasting a year or longer, but those measurements aren't interchangeable with IgM.

Parasites can also persist after symptoms improve. In a follow-up study of 84 antibody-positive blood donors, some had evidence of low-level infection that appeared intermittently during follow-up. The study used broader antibody testing and several methods of detecting parasites; it did not establish an IgM timeline.

PCR needs context too. After treatment, parasite DNA can remain detectable even when someone has recovered, so a positive PCR by itself does not always mean treatment failed. Antibody positivity, symptoms and parasite detection can resolve at different times.

Who Is at Greater Risk of Severe Illness

Babesiosis ranges from an infection you never notice to severe illness. Older adults, people without a working spleen, and people with impaired immunity are more likely to have complications. Cancer, advanced HIV infection and treatments such as rituximab can increase that risk.

A multicenter study of 225 people with babesiosis found more hospitalizations, complications and recurrences among those who were immunocompromised or had an absent or poorly functioning spleen. A separate hospital study linked breathing difficulties and abnormal chest X-rays with severe disease. These findings concern confirmed babesiosis; an IgM result does not predict how severe your illness will be.

Blood Donation and Silent Infection

Someone who feels well can still carry parasites that can be transmitted through donated blood. In an investigational study of 15,000 donations from areas with different exposure risks, about 1% of samples from the high-risk area were repeatedly reactive on a combined IgG/IgM antibody assay. That percentage was not the rate of active infection or positivity on this IgM screen.

A larger study screened 89,153 donations using antibody testing and PCR and found an association with fewer transfusion-transmitted infections. Current U.S. screening in designated risk areas uses specialized tests for parasite genetic material. A personal IgM screen serves a different purpose from the blood center's donation screening.

Lyme Disease and Other Tick Infections

The ticks that transmit Lyme disease can also transmit Babesia microti and anaplasmosis. Having antibodies to more than one organism can reflect exposure at different times. It doesn't establish that both infections are active together.

The studies below used different antibody measurements, sometimes tested for different Babesia species, and selected different populations. Their results describe exposure patterns within those groups.

Who Was StudiedWhat Was MeasuredWhat They Found
283 people in southern Sweden, including a group with Lyme antibodies and healthy controlsIgG to B. microti or B. divergens. Testing used serum in the Lyme-antibody group and plasma in controls.Babesia IgG was more than six times as common in the Lyme-antibody group: 16.3% versus 2.5%.
130 people in New York undergoing Lyme antibody testing, including negative resultsBoth IgM and IgG to B. microti in serum by IFAAbout one in four had both antibodies; this did not establish active babesiosis.
135 people with available follow-up serum from a Norwegian study of 188 people with a Lyme rashB. microti IgG in serum by IFANo B. microti IgG was detected.

Persistent fever during Lyme treatment or blood tests showing anemia or low platelets give a stronger reason to investigate another tick-borne infection than a positive Lyme antibody result alone. Lingering fatigue has several possible causes and doesn't establish babesiosis.

Reading the Pattern

  • IgM detected with a positive PCR or blood smear: supports infection in the right clinical setting. It doesn't precisely date when you acquired it, and a post-treatment PCR needs separate interpretation.
  • IgM detected, but PCR and blood smear negative: active infection is unconfirmed. Possible explanations include a resolving infection or a false-positive antibody reaction.
  • IgM detected without IgG: can occur early, but an isolated IgM result is less convincing if IgG remains absent on follow-up.
  • IgM not detected: may reflect no infection, an early antibody response, impaired antibody production, or infection with a different Babesia species.

When Results Can Be Misleading

  • Early sampling: antibodies may not yet be detectable even when parasites are present.
  • Impaired antibody production: immune disorders and drugs that deplete B cells, such as rituximab, can weaken the response. B cells are immune cells involved in making antibodies.
  • Nonspecific reactivity: an IgM reaction can occur without B. microti infection. A positive result is less convincing when exposure is unlikely or other tests do not support the diagnosis.
  • Persistent antibodies: IgM can remain detectable after recovery, so positivity alone doesn't establish continuing illness.
  • Species coverage: this assay targets B. microti. A negative result doesn't exclude babesiosis caused by species such as B. duncani or B. divergens.
  • Method and reporting differences: IFA screens, IFA titers and automated antibody assays provide different kinds of results. A detected screen cannot be interpreted as an antibody concentration or a measure of parasite burden.

Frequently Asked Questions

Panels containing Babesia Microti Antibody IgM Screen

Babesia Microti Antibody IgM Screen is included in these pre-built panels.

References

24 studies
  1. Peter J Krause, Paul G Auwaerter, Raveendhara R Bannuru, John a Branda, Yngve T Falck-ytter, Paul M Lantos, Valéry Lavergne, H Cody Meissner, Mikala C Osani, Jane Glazer Rips, Sunil K Sood, Edouard Vannier, Elizaveta E Vaysbrot, Gary P WormserClinical Infectious Diseases2021
  2. Centers for Disease Control and PreventionCDC2024
  3. Centers for Disease Control and PreventionCDC2024

Babesia Microti Antibody IgM Screen Testing Option

Babesia Microti Antibodies

$509

See whether your body has met the blood parasite behind babesiosis, and whether that encounter looks recent or long past.

Includes 4 biomarkers:
Babesia Microti Antibody IgM ScreenBabesia Microti IgM TiterBabesia Microti IgG TiterBabesia Microti Antibody IgG Screen
FSA/HSA eligible
No Rx needed
HIPAA compliant